AB Science S.A.
ABSCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $46,303 | $0 | $396,208 | $558,730 |
| - Cash | $7,987 | $6,066 | $7,269 | $8,721 |
| + Debt | $18,473 | $19,101 | $27,709 | $8,352 |
| Enterprise Value | $56,789 | $13,035 | $416,648 | $558,361 |
| Revenue | $1,072 | $970 | $958 | $1,607 |
| % Growth | 10.5% | 1.3% | -40.4% | – |
| Gross Profit | $1,248 | $587 | $927 | $1,496 |
| % Margin | 116.4% | 60.5% | 96.8% | 93.1% |
| EBITDA | -$4,917 | -$12,797 | -$15,528 | -$12,650 |
| % Margin | -458.7% | -1,319.3% | -1,620.9% | -787.2% |
| Net Income | -$7,831 | -$11,985 | -$13,615 | -$14,463 |
| % Margin | -730.5% | -1,235.6% | -1,421.2% | -900% |
| EPS Diluted | -0.15 | -0.24 | -0.29 | -0.3 |
| % Growth | 37.5% | 17.2% | 3.3% | – |
| Operating Cash Flow | $525 | -$16,871 | -$17,471 | -$17,178 |
| Capital Expenditures | -$155 | -$345 | -$644 | -$564 |
| Free Cash Flow | $370 | -$17,216 | -$18,115 | -$17,742 |